Skip to content

Phenotyping Adherence Through Technology-Enabled Reports and Navigation

Phenotyping Adherence Through Technology-Enabled Reports and Navigation: The PATTERN Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05766423
Enrollment
73
Registered
2023-03-13
Start date
2024-01-18
Completion date
2024-08-15
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence

Brief summary

This study is being conducted to adapt and pilot test a technology-enabled, primary care strategy for routinely monitoring medication use and adherence among older adults with multiple chronic conditions and polypharmacy.

Detailed description

Our study aims are to: Aim 1: Adapt the PATTERN intervention for use in primary care using input from key stakeholders. During Aim 1, the Northwestern research team will solicit opinions from key informants (patients, clinicians, practice administrators) to ensure PATTERN meets the needs of primary care. Aim 2: Assess the PATTERN intervention's feasibility and acceptability for use in primary care. During Aim 2, the investigators will conduct a 2-arm, patient-randomized controlled trial at a Northwestern Medicine primary care practice. Participants will be recruited and randomly assigned, using a random number generator application, to either the PATTERN intervention or usual care. Usual care refers to the normal standard clinical practices at the participating practice. Participants will be followed for 6 months.

Interventions

BEHAVIORALThe PATTERN Intervention

The intervention components include: 1. An adherence assessment that requests patients to self-report via MyChart about their medication use. The assessment provides a link between the health center and the patient ahead of a regularly scheduled clinic visit. 2. Care alert notifications directed to a nurse pool and/or member of the clinical care team when a medication adherence related problem is identified by the adherence assessment. The alert will also include the type of problem the patient is experiencing (cognitive, psychological, medical, regiment, social and/or economic). Once they receive these alerts, the care team can then activate appropriate staff and/or resources to respond.

Sponsors

The Claude D. Pepper Older Americans Independence Centers
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Each participant must: * Be an adult aged 65 or older * Speak English as their primary language * Have multiple chronic conditions * Be prescribed 8 or more medications * Be primarily responsible for administering own medication * Receive medical care at the participating primary care practice * Have access to the internet and an active email address * Be signed up for the patient portal (MyChart)

Exclusion criteria

No participant can: * Have severe, uncorrectable visual, hearing or cognitive impairments that would preclude study consent or participation

Design outcomes

Primary

MeasureTime frameDescription
Medication AdherenceAbout 2-4 WeeksParticipants' medication adherence will be measured at about 2-4 weeks after their clinic visit using a validated self-report measure: ASK-12. The 12-item measure assesses general medication attitudes and beliefs across three domains: 1) inconvenience/forgetfulness, 2) treatment beliefs, and 3) behaviors. Response options range from Strongly Disagree to Strongly Agree. Scores can range from 12-60 with higher scores representing greater barriers to adherence.

Secondary

MeasureTime frameDescription
FidelityBy the scheduled clinic visit (baseline)The investigators will examine participants' completion rates of the routine medication adherence assessment. This will be identified via the EHR.

Countries

United States

Participant flow

Pre-assignment details

Of 539 assessed participants, 73 met inclusion criteria and were randomized and allocated to Usual Care(n=36) and Intervention group(n=37). Of 36 allocated in Usual Care, 1 participant withdrawn and 3 consented but didn't schedule an interview, therefore were excluded from the study. Of 37 allocated in Intervention group, 5 participants consented but did not schedule an interview, therefore were excluded from the study.

Participants by arm

ArmCount
Usual Care
Usual care includes: 1. The normal standard clinical practices at the participating practice. 2. No specific materials to promote PATTERN, and no additional materials that include adherence assessments or care alert notifications.
32
The PATTERN Intervention
The intervention components include: 1. An adherence assessment completed by participants ahead of a regularly scheduled clinic visit. 2. Care alert notifications directed to a nurse pool and/or member of the clinical care team. The PATTERN Intervention: The intervention components include: 1. An adherence assessment that requests patients to self-report via MyChart about their medication use. The assessment provides a link between the health center and the patient ahead of a regularly scheduled clinic visit. 2. Care alert notifications directed to a nurse pool and/or member of the clinical care team when a medication adherence related problem is identified by the adherence assessment. The alert will also include the type of problem the patient is experiencing (cognitive, psychological, medical, regiment, social and/or economic). Once they receive these alerts, the care team can then activate appropriate staff and/or resources to respond.
32
Total64

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyConsented, not scheduled35
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicTotalThe PATTERN InterventionUsual Care
Age, Continuous75.0 years
STANDARD_DEVIATION 6.8
74.9 years
STANDARD_DEVIATION 6.1
75.1 years
STANDARD_DEVIATION 7.5
Health Status
Excellent
1 Participants0 Participants1 Participants
Health Status
Fair
20 Participants10 Participants10 Participants
Health Status
Good
29 Participants12 Participants17 Participants
Health Status
Poor
3 Participants2 Participants1 Participants
Health Status
Very good
11 Participants8 Participants3 Participants
Race/Ethnicity, Customized
Ethnicity
Hispanic or Latino
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Ethnicity
Not Hispanic or Latino
60 Participants31 Participants29 Participants
Race/Ethnicity, Customized
Ethnicity
Refused
3 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Race
Asian Indian
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Race
Black or African American
23 Participants12 Participants11 Participants
Race/Ethnicity, Customized
Race
Japanese
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
Refused
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Race
White
37 Participants18 Participants19 Participants
Sex: Female, Male
Female
42 Participants22 Participants20 Participants
Sex: Female, Male
Male
22 Participants10 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Medication Adherence

Participants' medication adherence will be measured at about 2-4 weeks after their clinic visit using a validated self-report measure: ASK-12. The 12-item measure assesses general medication attitudes and beliefs across three domains: 1) inconvenience/forgetfulness, 2) treatment beliefs, and 3) behaviors. Response options range from Strongly Disagree to Strongly Agree. Scores can range from 12-60 with higher scores representing greater barriers to adherence.

Time frame: About 2-4 Weeks

ArmMeasureValue (MEAN)Dispersion
Usual CareMedication Adherence21.6 score on a scaleStandard Deviation 6.2
The PATTERN InterventionMedication Adherence23.8 score on a scaleStandard Deviation 7
Secondary

Fidelity

The investigators will examine participants' completion rates of the routine medication adherence assessment. This will be identified via the EHR.

Time frame: By the scheduled clinic visit (baseline)

Population: Only the participants in PATTERN Intervention group were sent the medication adherence assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareFidelity0 Participants
The PATTERN InterventionFidelity15 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026